Search PDMR transactions

Notifier
Name of person with notification obligation
Peter Nicklin
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Peter Nicklin
Position
Chairman of the Board of Directors
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Hansabiopharma
Issuer´s LEI code
549300O897ZC5H7CY412
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Hansa Biopharma AB SE0002148817 Acquisition 17,067 Quantity 30.64 SEK 05/08/2025 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Hansa Biopharma AB SE0002148817 Acquisition 05/08/2025 NASDAQ STOCKHOLM AB 17,067 (Quantity) 30.64 SEK
Total: 17,067
<< Back